200 related articles for article (PubMed ID: 25015100)
1. Phenotypic severity of homozygous GCK mutations causing neonatal or childhood-onset diabetes is primarily mediated through effects on protein stability.
Raimondo A; Chakera AJ; Thomsen SK; Colclough K; Barrett A; De Franco E; Chatelas A; Demirbilek H; Akcay T; Alawneh H; ; Flanagan SE; Van De Bunt M; Hattersley AT; Gloyn AL; Ellard S;
Hum Mol Genet; 2014 Dec; 23(24):6432-40. PubMed ID: 25015100
[TBL] [Abstract][Full Text] [Related]
2. Childhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene.
Filibeli BE; Çatli G; Ayranci İ; Manyas H; Kirbiyik Ö; Dündar B
Hormones (Athens); 2022 Mar; 21(1):163-169. PubMed ID: 34697762
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.
Valentínová L; Beer NL; Staník J; Tribble ND; van de Bunt M; Hučková M; Barrett A; Klimeš I; Gašperíková D; Gloyn AL
PLoS One; 2012; 7(4):e34541. PubMed ID: 22493702
[TBL] [Abstract][Full Text] [Related]
4. Association of a homozygous GCK missense mutation with mild diabetes.
Marucci A; Biagini T; Di Paola R; Menzaghi C; Fini G; Castellana S; Cardinale GM; Mazza T; Trischitta V
Mol Genet Genomic Med; 2019 Jul; 7(7):e00728. PubMed ID: 31197960
[TBL] [Abstract][Full Text] [Related]
5. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
[TBL] [Abstract][Full Text] [Related]
6. Variable presentations of
Oza CM; Karguppikar MB; Khadilkar V; Khadilkar A
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228227
[TBL] [Abstract][Full Text] [Related]
7. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
8. Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation: initial response to oral sulphonylurea therapy.
Turkkahraman D; Bircan I; Tribble ND; Akçurin S; Ellard S; Gloyn AL
J Pediatr; 2008 Jul; 153(1):122-6. PubMed ID: 18571549
[TBL] [Abstract][Full Text] [Related]
9. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.
Gloyn AL; Odili S; Zelent D; Buettger C; Castleden HA; Steele AM; Stride A; Shiota C; Magnuson MA; Lorini R; d'Annunzio G; Stanley CA; Kwagh J; van Schaftingen E; Veiga-da-Cunha M; Barbetti F; Dunten P; Han Y; Grimsby J; Taub R; Ellard S; Hattersley AT; Matschinsky FM
J Biol Chem; 2005 Apr; 280(14):14105-13. PubMed ID: 15677479
[TBL] [Abstract][Full Text] [Related]
10. Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators.
Fenner D; Odili S; Hong HK; Kobayashi Y; Kohsaka A; Siepka SM; Vitaterna MH; Chen P; Zelent B; Grimsby J; Takahashi JS; Matschinsky FM; Bass J
J Biol Chem; 2011 Nov; 286(45):39560-72. PubMed ID: 21921030
[TBL] [Abstract][Full Text] [Related]
11. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.
Martínez R; Gutierrez-Nogués Á; Fernández-Ramos C; Velayos T; Vela A; ; Navas MÁ; Castaño L
Clin Endocrinol (Oxf); 2017 Jun; 86(6):778-783. PubMed ID: 28247534
[TBL] [Abstract][Full Text] [Related]
13. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
[TBL] [Abstract][Full Text] [Related]
14. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
15. Insight into the biochemical characteristics of a novel glucokinase gene mutation.
Shen Y; Cai M; Liang H; Wang H; Weng J
Hum Genet; 2011 Mar; 129(3):231-8. PubMed ID: 21104275
[TBL] [Abstract][Full Text] [Related]
16. Phenotype variability and neonatal diabetes in a large family with heterozygous mutation of the glucokinase gene.
Borowiec M; Mysliwiec M; Fendler W; Antosik K; Brandt A; Malecki M; Mlynarski W
Acta Diabetol; 2011 Sep; 48(3):203-8. PubMed ID: 21437567
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
18. Variability in the age at diagnosis of diabetes in two unrelated patients with a homozygous glucokinase gene mutation.
Durmaz E; Flanagan S; Berdeli A; Semiz S; Akcurin S; Ellard S; Bircan I
J Pediatr Endocrinol Metab; 2012; 25(7-8):805-8. PubMed ID: 23155716
[TBL] [Abstract][Full Text] [Related]
19. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
[TBL] [Abstract][Full Text] [Related]
20. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
